Viking Therapeutics (VKTX) Common Stock Issued (2015 - 2026)
Viking Therapeutics (VKTX) reported Common Stock Issued of $1 million for Q2 2026, up 81.5% from $551,000 a year earlier and up 100.0% from the prior quarter.
Viking Therapeutics (VKTX) Common Stock Issued (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Common Stock Issued came in at $5.09 million, down 65.6% year-over-year; for FY2025, it came in at $4.49 million, down 78.8% from FY2024.
- Common Stock Issued has a four-year compound annual growth rate of -12.4% (FY2021 to FY2025).
- By year, Common Stock Issued came in at $21.21 million in FY2024 (+61.1%), $13.17 million in FY2023, $848,000 in FY2022 (-88.9%) and $7.63 million in FY2021.
- Five-year quarterly Common Stock Issued spans a low of $5,000 in Q3 2021 and a high of $11.4 million in Q4 2024.
- Year over year, Common Stock Issued gained in three of the last seven quarters, with an average decline of 18.6%.
- The high point for year-over-year Common Stock Issued in five years was Q1 2023 (growth of 551.5%); the low point was Q3 2021 (a decline of 97.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $500,000 (Q1 2026), $3.16 million (Q4 2025) and $436,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Viking Therapeutics | 3.65 Bn | 884.58 Mn | - | 297.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 297.99 Mn |
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 436,000.00 |
| Jun 30, 2025 | 551,000.00 |
| Mar 31, 2025 | 349,000.00 |
| Dec 31, 2024 | 11.40 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Dec 31, 2023 | 6.57 Mn |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 150,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 614,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 1.90 Mn |
Viking Therapeutics Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=VKTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();